FMR LLC

Position in ORMP — Oramed Pharmaceuticals Inc.

CIK 315066 BOSTON, MA

Position in ORMP

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$680

-$745 QoQ

Shares Held

200

-60.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2022

12 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

FMR LLC holds $49,682,018,247 across 354 Biotechnology names. ORMP ranks #326 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	14,579,166	$4,823,808,652
2	ARGX	Argenx SE	4,991,034	$3,644,702,577
3	MRNA	Moderna, Inc.	45,672,024	$2,320,138,818
4	ROIV	Roivant Sciences Ltd.	77,981,253	$2,160,080,705
5	INSM	INSMED Inc	13,160,167	$2,151,950,504
6	IONS	Ionis Pharmaceuticals Inc	24,556,637	$1,843,957,869
7	RPRX	Royalty Pharma plc	25,152,242	$1,206,553,046
8	REGN	Regeneron Pharmaceuticals, Inc.	1,518,192	$1,173,015,865

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$680	200	-60.0%	Shares	Defined	2026-05-15
2025-12-31	$1,425	500	0.0%	Shares	Defined	2026-02-17
2025-09-30	$1,320	500	-70.6%	Shares	Defined	2025-11-13
2024-12-31	$4,114	1,700	+13.3%	Shares	Defined	2025-02-13
2024-09-30	$3,660	1,500	+66.7%	Shares	Defined	2024-11-13
2023-12-31	$2,079	900	0.0%	Shares	Defined	2024-02-13
2023-09-30	$2,349	900	-35.7%	Shares	Defined	2023-11-13
2023-03-31	$3,052	1,400	-96.3%	Shares	Defined	2023-08-11
2022-12-31	$453,362	37,686	0.0%	Shares	Defined	2023-02-13
2022-09-30	$244,205	37,686	-55.1%	Shares	Defined	2022-11-10
2022-06-30	$384,064	83,857	+73.4%	Shares	Defined	2022-08-12
2022-03-31	$418,314	48,360	—	Shares	Defined	2022-05-13
No filing history on record for this holder in this stock.